NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myelomonocytic leukaemia

Authors: Professor Ken Stein , George E, Holden J, Miller W
Published: 1st April 2011
Theme: Complex Care
Type: Paper
DOI: 10.1016/S1470-2045(11)70066-3

Reference:

Miller Whitney, Holden J, George E, Stein K. NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myelomonocytic leukaemia. The Lancet Oncology 2011;12(4): 326-327.